8. COMMON STOCK	12 Months Ended
Sep. 30, 2018
Notes
8. COMMON STOCK	8. COMMON STOCK During the year ended September 30, 2017, the Company sold 1,032,539 shares of common stock at prices ranging from $0.51 to $1.00 per share for an aggregate purchase price of $860,045. On March 31, 2017, Kenichi Miura exercised his right to convert the Amended Note to shares of the Corporation’s common stock (the “Conversion”), at the price of $0.51 per share, in accordance with the terms and conditions of the Convertible Note Purchase Agreement, thus equating to a conversion of $606,000 [i.e., $600,000 principal, plus $6,000in accrued interest] to the equivalent 1,188,236 shares of the Corporation’s common stock. During the year ended September 30, 2017, the Company sold 1,766,242 shares of treasury stock at $0.51 per share, for an aggregate purchase price of $900,783. During May 2017, the Company agreed to amend Nagashima Takayuki’s $100,000 short-term loan to a convertible loan with a conversion price of $0.51 per share. Nagashima Takayuki then converted this loan to 196,078 shares of the Company’s common stock. During August 2017, the Company issued 34,602 shares of treasury stock at $0.43 per share, for services and recognized stock compensation expense of $14,879. During year ended September 30, 2018, the Company sold 4,808,966 shares of common stock at prices ranging from 0.51 to 1.20 per share, for aggregate purchase price of $4,542,659. The Company incurred stock issuance costs of $157,690 which includes the fair value of 19,667 shares, amounting to $23,600, issued to settle fees owed to a consultant. During year ended September 30, 2018, the Company issued 34,602 shares with a fair value of $14,880 to a consultant for services received.

8. COMMON STOCK

12 Months Ended

Sep. 30, 2018

8. COMMON STOCK

During the year ended September 30, 2017, the Company sold 1,032,539 shares of common stock at prices ranging from $0.51 to $1.00 per share for an aggregate purchase price of $860,045.

On March 31, 2017, Kenichi Miura exercised his right to convert the Amended Note to shares of the Corporation’s common stock (the “Conversion”), at the price of $0.51 per share, in accordance with the terms and conditions of the Convertible Note Purchase Agreement, thus equating to a conversion of $606,000 [i.e., $600,000 principal, plus $6,000in accrued interest] to the equivalent 1,188,236 shares of the Corporation’s common stock.

During the year ended September 30, 2017, the Company sold 1,766,242 shares of treasury stock at $0.51 per share, for an aggregate purchase price of $900,783.

During May 2017, the Company agreed to amend Nagashima Takayuki’s $100,000 short-term loan to a convertible loan with a conversion price of $0.51 per share. Nagashima Takayuki then converted this loan to 196,078 shares of the Company’s common stock.

During August 2017, the Company issued 34,602 shares of treasury stock at $0.43 per share, for services and recognized stock compensation expense of $14,879.

During year ended September 30, 2018, the Company sold 4,808,966 shares of common stock at prices ranging from 0.51 to 1.20 per share, for aggregate purchase price of $4,542,659. The Company incurred stock issuance costs of $157,690 which includes the fair value of 19,667 shares, amounting to $23,600, issued to settle fees owed to a consultant.

During year ended September 30, 2018, the Company issued 34,602 shares with a fair value of $14,880 to a consultant for services received.